Literature DB >> 10910740

Self-tolerance: context dependent tuning of T cell antigen recognition.

Z Grossman1, W E Paul.   

Abstract

Physiological messages to cells are encoded in the magnitude, and in the time- and space-contingencies, of sets of stimuli. In particular, individual T cells continuously integrate antigenic and other signals and respond differentially to the rate of change in the level of stimulation, translated intracellularly into 'metabolic perturbations'. The organization of the immune response at the cell-population level in space and time is also conductive to discriminating the magnitude of 'system perturbations'. In this way, the immune system was 'designed' to respond in a characteristic explosive way mainly to episodes of infection and not to the continuous presence of self-antigens. T cells are selected to be moderately autoreactive, and the degree of autoreactivity that they express is continuously controlled through activation-threshold tuning. Their level of autoreactivity is maintained in a range that facilitates survival and self-renewal and is probably used in performing some immunoregulatory functions and possibly other physiological functions. Autoreactivity and outward-directed immunity are regulated simultaneously and interactively through the interplay of selection, tuning, controlled activation and feedback. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910740     DOI: 10.1006/smim.2000.0232

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  28 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

2.  Activation-threshold tuning in an affinity model for the T-cell repertoire.

Authors:  Almut Scherer; André Noest; Rob J de Boer
Journal:  Proc Biol Sci       Date:  2004-03-22       Impact factor: 5.349

3.  The effects of thymic selection on the range of T cell cross-reactivity.

Authors:  Dennis L Chao; Miles P Davenport; Stephanie Forrest; Alan S Perelson
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

4.  On the definition of a criterion of immunogenicity.

Authors:  Thomas Pradeu; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

5.  MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Authors:  Ursula B Fischer; Erica L Jacovetty; Ricardo B Medeiros; Brian D Goudy; Traci Zell; Jeannie-Beth Swanson; Elizabeth Lorenz; Yoji Shimizu; Mark J Miller; Alexander Khoruts; Elizabeth Ingulli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

6.  B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.

Authors:  Yan Li; Gianluca Toraldo; Aimin Li; Xiaoying Yang; Hongying Zhang; Wei-Ping Qian; M Neale Weitzmann
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 7.  Toward effective immunotherapy for the treatment of malignant brain tumors.

Authors:  Duane A Mitchell; John H Sampson
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

8.  Feedback regulation of proliferation vs. differentiation rates explains the dependence of CD4 T-cell expansion on precursor number.

Authors:  Gennady Bocharov; Juan Quiel; Tatyana Luzyanina; Hagit Alon; Egor Chiglintsev; Valery Chereshnev; Martin Meier-Schellersheim; William E Paul; Zvi Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-03       Impact factor: 11.205

Review 9.  Self-reactivity as the necessary cost of maintaining a diverse memory T-cell repertoire.

Authors:  Nevil J Singh
Journal:  Pathog Dis       Date:  2016-09-11       Impact factor: 3.166

10.  Density dependent re-tuning of autoreactive T cells alleviates their pathogenicity in a lymphopenic environment.

Authors:  Eleanore Chuang; Marilyn Augustine; Matthew Jung; Ronald H Schwartz; Nevil J Singh
Journal:  Immunol Lett       Date:  2017-10-31       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.